SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte Inc. today announced a partnership with AstraZeneca to develop a state-of-the-art automated pharmaceutical compound management system based on its revolutionary Echo® acoustic liquid handling technology. The new system, which will employ storage tubes compatible with acoustic liquid handling, will be deployed at the AstraZeneca MRC UK Centre for Lead Discovery in Cambridge.
Acoustic liquid handling technology is contactless, eliminating the use of pipettes and reducing compound volumes. Labcyte will combine its acoustic liquid handling with its Access™ robotic workstations to create a compact and fully automated system for the production of assay-ready plates from acoustic storage tubes.
Acoustic liquid handling technology is contactless, eliminating the use of pipettes and reducing compound volumes. Labcyte will combine its acoustic liquid handling with its Access™ robotic workstations to create a compact and fully automated system for the production of assay-ready plates from acoustic storage tubes.
